Findings from the first multi-site examination of the effectiveness of an injectable, long-acting formulation of naltrexone show significantly fewer drinking days and a greater likelihood of total abstinence during the three-month study period.
More: Finally, A Pill for Alcoholism? | Naltrexone Facts